Faculty Information - Satoshi Nagase

（Last updated : 2025-09-11 16:47:42）

Satoshi Nagase
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 3,

Position Professor

■ Journal

1.	2025/08/26	Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis
2.	2025/08/25	Automated Assessment to Predict Lethal Arrhythmias in Brugada Syndrome: Significance of R' in Lead III
3.	2025/07/24	Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial
4.	2025/06/04	Virtual endoscopic imaging of the heart using photon-counting detector computed tomography for electrophysiologists
5.	2025/04/09	Prevalence of ventricular parasystole in patients with cardiac sarcoidosis: correlation between parasystole and inflammation in ventricular fibrillation
6.	2025/04/05	Aging of the tricuspid valve annulus detected by photon-counting detector computed tomography: Importance of aortic root compression on occurrence of arrhythmias
7.	2025/02/28	Mid-Range Paced-QRS as an Independent Negative Predictor of Cardiac Events - Right Ventricular Pacing Implications
8.	2025/02/05	Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study) - Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial
9.	2025/02	Reply: Repolarization Mapping in Brugada Syndrome Patients: How to Deal With Monophasic Complexes?
10.	2025/01/03	Identifying non-responders to cardiac resynchronization therapy in the non-left bundle branch block
11.	2025/01	Reply: Routine Electrical Substrate Mapping in Brugada Syndrome: Is Direct Epicardial Assessment Truly Necessary?
12.	2024/12	Yield of Genetic Testing for Long-QT Syndrome in Elderly Patients With Torsades de Pointes
13.	2024/09/14	Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection Fraction
14.	2024/09	Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy
15.	2024/09	Significance of extensive ablation targeting Purkinje-muscle junction of all the left fascicles for suppressing Purkinje-related ventricular arrhythmias: A case report
16.	2024/08/23	Clinical Usefulness of the Active Fixation Quadripolar Left Ventricular Lead Compared With the Passive Fixation Quadripolar Lead in Cardiac Resynchronization Therapy
17.	2024/08/23	SMART pass Automatic Deactivation of Subcutaneous Implantable Cardioverter-Defibrillators
18.	2024/08	Local dispersion of repolarization in the occurrence of ventricular fibrillation in Brugada syndrome: Possibility of phase 2 reentry?
19.	2024/08	Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy
20.	2024/07/31	Late Gadolinium Enhancement in Early Repolarization Syndrome
21.	2024/07/22	Multicenter Prospective Randomized Study Comparing the Incidence of Periprocedural Cerebral Embolisms Caused by Catheter Ablation of Atrial Fibrillation Between Cryoballoon and Radiofrequency Ablation (Embo-Abl Study)
22.	2024/07/10	Possible feature of intrascar ventricular tachycardia: A case of recording constant diastolic potential within extensive scar despite irregular pleomorphic QRS manifestation
23.	2024/07	Demonstration of Arrhythmia Substrate-Associated Dispersion of Repolarization by Epicardial Unipolar Mapping in Brugada Syndrome
24.	2024/06/25	Clinical Significance of Atrial Tachyarrhythmia Duration for Ventricular Arrhythmia in Patients With Cardiac Resynchronization Therapy
25.	2024/04/17	Effect of adaptive cardiac resynchronization therapy in heart failure patients with pacemaker dependency
26.	2024/02/16	Successful release of multiple splines of a multipolar catheter entrapped in a mechanical mitral valve: video presentation of a validated method
27.	2024/02/02	Implantable loop recorder uncovered torsades de pointes in long-QT syndrome type 1 with multi cause of syncope
28.	2024/02	Implications of ventricular arrhythmia after cardiac resynchronization therapy
29.	2023/12/15	Systematic observation-based diagnosis of atrioventricular nodal reentrant tachycardia with a bystander concealed nodoventricular pathway
30.	2023/11	Abnormal Arrhythmogenic Substrate Outside the Right Ventricular Outflow Tract Detected by a Drug Challenge Test in a Patient With Brugada Syndrome
31.	2023/11	The Mechanism of Brugada Syndrome: Is it Induced Only by Conduction Disturbance?
32.	2023/10/24	N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
33.	2023/09/29	Global epicardial J wave with unipolar recording in both ventricles in a case of Brugada syndrome: Masked early repolarization syndrome type 3
34.	2023/09/05	Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac Function
35.	2023/09	Significance of effective cardiac resynchronization therapy pacing for clinical responses: An analysis based on the effective cardiac resynchronization therapy algorithm
36.	2023/08/03	Dynamics of unipolar J-ST elevation coupled to bipolar delayed potentials on the epicardium in Brugada syndrome: a case report
37.	2023/08	Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score-weighted analyses of a nationwide claim-based database
38.	2023/05/29	Interference of cardiac implantable electronic devices and computed tomography imaging in the current era with a phantom model
39.	2023/05	Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation
40.	2023/03/14	Combination of low-dose quinidine and verapamil for multifocal ectopic Purkinje-related premature contractions in a patient with SCN5A mutation
41.	2023/03	Structural characteristics of patients with superior vena cava foci initiating atrial fibrillation: Analysis with electrocardiogram-triggered computed tomography
42.	2023/02	A multicenter prospective randomized study comparing the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation between cryoballoon and radiofrequency ablation (Embo-Abl study): Study design
43.	2023/01/13	Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases
44.	2023/01/11	Real-world comparison of in-hospital complications after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database
45.	2022/12/23	Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope
46.	2022/10/25	JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
47.	2022/10/25	JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.
48.	2022/09/30	Multipolar catheter entrapment in a mechanical mitral valve and successful retrieval of a sheared spine straying into the coronary artery
49.	2022/09	Unusual response to a ventricular extrastimulus during a narrow QRS tachycardia: What is the mechanism?
50.	2022/07/11	Manifestation of epicardial type 1 electrocardiogram pattern with temperature elevation during open chest surgery in a patient with Brugada syndrome.
51.	2022/07/01	Left Ventricular Abnormality and Covert Atrial Fibrillation in Embolic Stroke of Undetermined Source.
52.	2022/07	Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
53.	2022/06/25	Cryoballoon Ablation versus Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation (CRRF-PeAF): Protocol for a Prospective, Multicenter, Randomized, Controlled Study.
54.	2022/06/24	A case of antidromic atrioventricular reciprocating tachycardia via the atriofascicular pathway with suspected minor manifest fusion during ventricular pacing.
55.	2022/06	A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
56.	2022/06	Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database.
57.	2022/05/12	Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
58.	2022/05	Impact of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after catheter ablation of atrial fibrillation.
59.	2022/03/06	Frequent His-Purkinje discharges with longitudinal dissociation in a case with multiple premature ventricular contractions suppressed by co-treatment with verapamil and quinidine
60.	2022/03/04	Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy
61.	2022/03	Zero-fluoroscopy ablation in patients with cardiac electronic implantable devices.
62.	2022/01	Retrograde penetration pacing into the conduction system as an alternative approach of his-bundle pacing: Retrograde penetration pacing into the conduction system.
63.	2022	Impact of Pre-Ablation Direct Current Cardioversion for Persistent Atrial Fibrillation to Predict Recurrence of Atrial Fibrillation after Catheter Ablation.
64.	2021/12/30	Multifocal Purkinje-related premature contractions and electrical storm suppressed by quinidine and verapamil in a case with short-coupled ventricular fibrillation
65.	2021/12/07	Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings
66.	2021/11	Comparison Between Septal Pacing With the Catheter Delivery System and Apical Pacing With the Stylet Delivery System for Ventricular Lead Placement: A Randomized Controlled Trial.
67.	2021/10/25	Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome.
68.	2021/08/30	Prevalence and characteristics of the Brugada electrocardiogram pattern in patients with arrhythmogenic right ventricular cardiomyopathy.
69.	2021/08/10	Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia.
70.	2021/07/31	Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
71.	2021/07/30	Pulmonary Vein Isolation and Pacemaker Implantation in a Patient with Dextrocardia Situs Inversus.
72.	2021/07	Narrow QRS complex tachycardia with a 2:1 atrioventricular block: What is the mechanism.
73.	2021/06	Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROAD-DPC Study.
74.	2021/05	An anatomical approach to determine the location of the sinoatrial node during catheter ablation.
75.	2021/05	Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure.
76.	2021/04/08	Atrioventricular nodal reentrant tachycardia in a nonagenarian-Triple traps of AV block.
77.	2021/04	Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
78.	2021/03	High-risk atrioventricular block in Brugada syndrome patients with a history of syncope.
79.	2021	Unusual Overlapping Cardiac Sarcoidosis and Long-QT Type 3 Induced Ventricular Fibrillation.
80.	2020/11/25	Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline　- A Multicenter Validation Study.
81.	2020/11/25	Novel Non-Invasive Index for Prediction of Responders in Cardiac Resynchronization Therapy Using High-Resolution Magnetocardiography.
82.	2020/11/01	Intra-day change in occurrence of out-of-hospital ventricular fibrillation in Japan: The JCS-ReSS study.
83.	2020/11	Clinical impact of left ventricular paced conduction disturbance in cardiac resynchronization therapy.
84.	2020/08/17	A case of macroreentrant atrial tachycardia between a persistent left superior vena cava and the left atrium with a decremental property.
85.	2020/08/11	Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A.
86.	2020/07	Identification of malignant early repolarization pattern by late QRS activity in high-resolution magnetocardiography.
87.	2020/06/01	Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome
88.	2020/05	Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with cardiac resynchronization therapy devices.
89.	2020/03/15	Risk stratification in Brugada syndrome - Significance of ECG and depolarization abnormality
90.	2019/12/25	Efficacy of a Device-Based Continuous Optimization Algorithm for Patients With Cardiac Resynchronization Therapy.
91.	2019/11/01	Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone
92.	2019/10	Very long-term prognosis in patients with right ventricular apical pacing for sick sinus syndrome.
93.	2019/09/01	Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up.
94.	2019/09	A safe and simple approach to avoid fast junctional rhythm during ablation in patients with atrioventricular nodal reentrant tachycardia.
95.	2019/08/23	Earthquake-Induced Torsade de Pointes in Long-QT Syndrome.
96.	2019/03/29	Comparing the catheter delivery system and the stylet delivery system for ventricular lead placement in pacemaker implantation-The CATS delivery system randomized controlled trial.
97.	2019/03/07	Feasibility of late gadolinium enhancement magnetic resonance imaging to detect ablation lesion gaps in patients undergoing cryoballoon ablation of paroxysmal atrial fibrillation.
98.	2019/03	Performance of an atrial fibrillation detection algorithm using continuous pulse wave monitoring.
99.	2019/02/25	Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
100.	2019/01	Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation.
101.	2018/11/06	Low Voltage Type 1 Electrocardiogram is Associated with Fatal Ventricular Tachyarrhythmia in Brugada Syndrome
102.	2018/09/18	Sex-Dependent Phenotypic Variability of an SCN5A Mutation: Brugada Syndrome and Sick Sinus Syndrome.
103.	2018/09	Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.
104.	2018/06/01	Feasibility evaluation of long-term use of beta-blockers and calcium antagonists in patients with Brugada syndrome.
105.	2018/05/30	HCN4-Overexpressing Mouse Embryonic Stem Cell-Derived Cardiomyocytes Generate a New Rapid Rhythm in Rats with Bradycardia.
106.	2018/03	Change in QRS morphology as a marker of spontaneous elimination in verapamil-sensitive idiopathic left ventricular tachycardia.
107.	2018/02/07	Significance of Coronary Artery Spasm Diagnosis in Patients With Early Repolarization Syndrome
108.	2018/01	Impact of premature activation of the right ventricle with programmed stimulation in Brugada syndrome.
109.	2017/12/25	Isolated late activation detected by magnetocardiography predicts future lethal ventricular arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy.
110.	2017/10	Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
111.	2017/08/15	Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
112.	2017/08	"Window Sliding" analysis combined with high-density and rapid electroanatomical mapping: its efficacy and the outcome of catheter ablation of atrial tachycardia.
113.	2017/07	Tachycardia-induced J-wave changes in patients with and without idiopathic ventricular fibrillation.
114.	2017/04	Differences in the onset mode of ventricular tachyarrhythmia between patients with J wave in anterior leads and those with J wave in inferolateral leads.
115.	2017/01/26	Local Left Ventricular Epicardial J Waves and Late Potentials in Brugada Syndrome Patients with Inferolateral Early Repolarization Pattern.
116.	2017	Local activation delay exacerbates local J-ST elevation in the epicardium: electrophysiological substrate in Brugada syndrome
117.	2016/09/23	Diagnostic Value of Right Ventricular Dysfunction in Tachycardia-Induced Cardiomyopathy Using Cardiac Magnetic Resonance Imaging.
118.	2016/07/25	Activation pattern of the polymorphic ventricular tachycardia and ventricular fibrillation on body surface mapping in patients with Brugada syndrome.
119.	2015/09/18	Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.
120.	2015	Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block.
121.	2015	Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest – Prognostic Value of Combined Risk Factors –
122.	2014/09	Association of early repolarization with long-term mortality and major adverse cardiac events in patients with ST-segment elevation myocardial infarction.
123.	2014/05/27	Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
124.	2014	Deep-inspiration test. A novel and simple technique of unmasking type 1 ECG in Brugada syndrome.
125.	2014	Left ventricular epicardial electrogram recordings in idiopathic ventricular fibrillation with inferior and lateral early repolarization.
126.	2014	Multiform premature ventricular contractions and polymorphic ventricular tachycardia caused by Purkinje activity with slow conduction in idiopathic ventricular fibrillation
127.	2013	Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
128.	2013	Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: A novel risk factor for Brugada syndrome with ventricular fibrillation.
129.	2012/08/23	Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
130.	2012	Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
131.	2012	Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in patients with systolic heart failure.
132.	2012	Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome.
133.	2011/11	Intermittent arm ischemia induces vasodilatation of the contralateral upper limb
134.	2011	Circulating KCNH2 Current-Activating Factor in Patients with Heart Failure and Ventricular Tachyarrhythmia.
135.	2011	Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
136.	2011	Spontaneous ECG alterations predict ventricular fibrillation in Brugada syndrome.
137.	2011	Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure
138.	2010	Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
139.	2010	Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
140.	2010	Atrial electrophysiological and structural remodeling in high-risk patients with Brugada syndrome: assessment with electrophysiology and echocardiography.
141.	2010	Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
142.	2010	Cytokine reducing effect of azelnidipine in human peripheral blood mononuclear cells.
143.	2010	Efficacy of Low-dose Bepridil for Prevention of Ventricular Fibrillation in Brugada Syndrome Patients with and without SCN5A Mutation.
144.	2010	Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: Detection of type 1 electrocardiogram in the right ventricular outflow tract.
145.	2010	Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
146.	2010	SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.
147.	2009	4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes.
148.	2009	Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome.
149.	2009	Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
150.	2009	Fulminant eosinophilic myocarditis associated with visceral larva migrans caused by Toxocara canis infection.
151.	2009	Quantitative analysis and characteristics of the electrograms recorded within the non-coronary aortic sinus of Valsalva.
152.	2009	Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy.
153.	2008	Arterial Stiffening is Associated with Exercise Intolerance and Hyperventilatory Response in Patients with Coronary Artery Disease
154.	2008	Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds.
155.	2008	Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
156.	2008	Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy.
157.	2008	Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
158.	2008	Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
159.	2008	Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension.
160.	2008	Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model.
161.	2008	Repolarization measurement in Brugada syndrome. Letter to the Editor. Reply.
162.	2008	Usefulness of a long-straight sheath for atrial lead insertion at the right atrial septum.
163.	2007	Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome.
164.	2007	Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
165.	2007	Long-RP supraventricular tachycardia: what is the mechanism?
166.	2007	Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis.
167.	2006	Aldosterone synthesis and cytokine production in human peripheral blood mononuclear cells.
168.	2006	Anti-inflammatory effect of spironolactone on human peripheral blood mononuclear cells.
169.	2006	Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
170.	2006	Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure.
171.	2006	Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome.
172.	2005	Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy.
173.	2004	Evaluation of the usefulness of recording the ECG in the 3rd intercostal space and prevalence of Brugada-type ECG in accordance with recently established electrocardiographic criteria.
174.	2004	Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
175.	2004	Sinus node function in patients with Brugada-type ECG.
176.	2004	Usefulness of body surface mapping to differentiate patients with Brugada syndrome from patients with asymptomatic Brugada syndrome.
177.	2003	Risk stratification for asymptomatic patients with Brugada syndrome - Prediction of induction of ventricular fibrillation by noninvasive methods.
178.	2003	Site-specific arrhythmogenesis in patients with Brugada syndrome.
179.	2003	Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
180.	2002	Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.
181.	2002	Carvedilol decreases elevated oxidative stress in human failing myocardium.
182.	2002	Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead.
183.	2002	Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome.
184.	2001	Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death.
185.	2000	Effects of myocardial perfusion on QT dispersion in patients with hypertrophic cardiomyopathy.
Display 5 items
Display all(185)

■ Presentation

2024/09/26

Demonstration of Arrhythmia Substrate-associated Dispersion of Repolarization by Epicardial Unipolar Mapping in Brugada Syndrome （Speech，Panelist at Symposium/Workshop (Appointed)）